SEOUL, July 20 (Korea Bizwire) — South Korea’s state-run National Institute of Infectious Diseases (NIID) said Wednesday it has reached an agreement with Moderna Inc., a U.S. biotech company, to cooperate in the development of a messenger RNA (mRNA) vaccine candidate for severe fever and thrombocytopenia syndrome (SFTS). The institute said the deal, signed Monday, [...]
SEOUL, July 19 (Korea Bizwire) – Moderna Inc., a U.S. biotech company specializing in messenger RNA (mRNA) coronavirus vaccines, is committed to making its new bivalent vaccine candidate available next month, which reportedly demonstrates a superior antibody response against omicron variants. The company announced in June that the new bivalent coronavirus booster candidate, named mRNA-1273.214, [...]
NEW YORK/SEOUL, Aug. 14 (Korea Bizwire) — South Korea has asked U.S. drugmaker Moderna Inc. to speed up its delivery of COVID-19 vaccines to Seoul in accordance with a prior contract, visiting government officials said Saturday. The request was made during a South Korean government delegation’s visit to the headquarters of Moderna in the U.S. [...]
SEOUL, Aug. 9 (Korea Bizwire) — Moderna Inc. has notified South Korean health authorities that it will supply less than half of the 8.5 million doses of its COVID-19 vaccine planned for August, Seoul officials said Monday, spawning concerns that the country’s vaccine rollout may hit a snag. The U.S. vaccine maker said some problems [...]
SEOUL, July 19 (Korea Bizwire) — South Korean firms are replacing Moderna’s COVID-19 vaccine with Pfizer’s for their in-house inoculation programs, industry insiders said Monday, due to the former’s delayed supply schedule. Samsung Electronics Co. said vaccines that will be administered to its workers have been switched from Moderna’s to Pfizer’s following health authorities’ notification. [...]
SEOUL, May 23 (Korea Bizwire) – South Korea, touted as one of most successful countries in containing the new coronavirus pandemic without lockdowns, is gearing up for its next step to emerge as a global vaccine hub, with four COVID-19 vaccines already being or set to be produced here. The country’s vision to become a [...]
WASHINGTON/SEOUL, May 22 (Korea Bizwire) — Samsung Biologics, a South Korean biopharmaceutical firm, signed a deal Saturday to manufacture Moderna’s COVID-19 vaccine at its local factory. Under the agreement, the biotech unit of Samsung Group will provide the U.S. drugmaker with contract manufacturing organization (CMO) services for its mRNA vaccine. It means that some of [...]
SEOUL, Dec. 31 (Korea Bizwire) — South Korea on Thursday signed a deal with U.S. biotech company Moderna to buy new coronavirus vaccine doses for 20 million people, with the supply to begin in the second quarter of next year, health authorities said. Following the deal, the total amount of COVID-19 vaccines South Korea has [...]
SEOUL, Dec. 29 (Korea Bizwire) — U.S. biotech company Moderna has agreed to supply new coronavirus vaccine doses for 20 million people to South Korea starting in the second quarter of next year, Cheong Wa Dae announced Tuesday. The agreement was reached in a videoconference between President Moon Jae-in and Moderna CEO Stephane Bancel held [...]